Premium
Escitalopram for recurrent isolated sleep paralysis
Author(s) -
Hintze Jonathan P.,
Gault Dominic
Publication year - 2020
Publication title -
journal of sleep research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.297
H-Index - 117
eISSN - 1365-2869
pISSN - 0962-1105
DOI - 10.1111/jsr.13027
Subject(s) - escitalopram , sleep paralysis , anxiety , paralysis , medicine , sleep (system call) , intervention (counseling) , anesthesia , psychology , psychiatry , sleep disorder , insomnia , excessive daytime sleepiness , computer science , antidepressant , operating system
Recurrent isolated sleep paralysis can be very disturbing and provoke anxiety. The majority of patients can be treated conservatively with cognitive and behavioural therapies. However, some patients may benefit from a pharmacologic intervention. With only scant available evidence, there are currently no standardized pharmacologic treatment recommendations for recurrent isolated sleep paralysis. We report the first two cases of escitalopram used to successfully treat recurrent isolated sleep paralysis. Escitalopram, the most selective of the selective serotonin reuptake inhibitors, generally improves subjective sleep quality, making it an appealing treatment option.